Moxicip IV belongs to the fourth-generation fluoroquinolone antibiotics. It works by inhibiting bacterial topoisomerase IV and DNA gyrase, preventing DNA replication and leading to cell death.
Recommended for:
Moxicip IV should be administered as a slow intravenous infusion over 60 minutes. Dosage and treatment duration are determined by the physician based on the type and severity of the infection.
Contraindications
Side effects